The US FDA has approved Pfizer’s vaccine Penbraya for ages 10 to 25, offering protection against the five main types of bacteria causing meningitis and blood poisoning. As a two-dose vaccine administered six months apart, it combines elements of Trumenba and Menveo and reduces the current four-dose regimen for full protection. The CDC will discuss recommendations for Penbraya’s use in adolescents and young adults.
Go Module Mirror served backdoor to devs for 3+ years
Google’s mirror proxy for Go programming language developers promoted a backdoored package for over three years. The service, Go Module Mirror, fastens and verifies downloads’
